Last updated 2026-06-18
- Went public (AIFF), Nov 2021
- Raised $28M Series C, Nov 2015
- Raised $8.8M PIPE, Feb 2025
Total raised
$82.6M
Last: PIPE 2025-02
Stage
Public
Founded
2006
Headcount
26
HQ
Herzliya, Israel
Sector
Health Tech & Life Sciences
About
Firefly Neuroscience’s Brain Network Analytics (BNA™) technology provides an objective assessment of cognition (brain function). It records and compares how a brain functions to an FDA-cleared, normative, age-matched database using AI and advanced signal processing.
This allows clinicians and their patients to make informed, objective therapy and disease management decisions and track changes over time. Firefly Neuroscience takes the guesswork and subjectivity out of managing mental illnesses and cognitive disorders.
Funding history · 10 rounds · $82.6M total
2025-02
PIPE
$8.8M
2024-12
PIPE
$12.4M
2023-06
Undisclosed Round
$508K
2020-06
E Round
$3.5M
2019-04
D Round
$2.3M
2019-03
Grant
$3.3M
2018-06
D Round
$6.4M
2015-11
2011-12
A Round
$13.8M
2006-06
Seed
$3.6M
Q&A
- When did Firefly Neuroscience go public and on which exchange?
- Firefly Neuroscience went public on NASDAQ in November 2021, trading under the ticker AIFF.
- What is Firefly Neuroscience's primary business?
- Firefly Neuroscience focuses on measuring brain health through its Brain Network Analytics (BNA™) technology, which provides an objective assessment of cognition using AI and advanced signal processing.
- What was Firefly Neuroscience's most recent funding round?
- Firefly Neuroscience completed a PIPE round in February 2025, raising $8,800,000.
- How many employees does Firefly Neuroscience currently have?
- Firefly Neuroscience has 11-50 employees.
- What was the total amount raised by Firefly Neuroscience to date?
- Firefly Neuroscience has raised a total of $82,588,527 USD.
- When was Firefly Neuroscience founded?
- Firefly Neuroscience was founded in January 2006.
- Which company did Firefly Neuroscience acquire recently?
- Firefly Neuroscience acquired Evoke Neuroscience in May 2025 for $6,000,000.
- Who is the current CEO of Firefly Neuroscience?
- Jon Olsen is the CEO of Firefly Neuroscience.
Team · 7
executives
executives
executives
executives
Chen Golan
executives
executives
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcareMedical Decision Support
Technologies
Artificial IntelligenceMachine LearningPlatforms & InterfacesSoftware
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticalsHealthcareProviders
Business model
B2B2C
Highlights
1 PatentsVerified
Tags
machine-learningpersonalizationbrain-disorderalzheimers-diseasedecision-supportmappingmental-healthpsychiatrydigital-healthcareneurologypharma-companiesmedical-devicesclinical-trialsimaginghealthcare-providersdegenerative-diseasesartificial-intelligencenon-invasivemedical-cannabisdiagnosticsparkinsonmedical-technologiesdeep-learningdoctorssaas
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | fireflyneuro.com/ |
|---|---|
| linkedin.com/company/2531441 | |
| Crunchbase | crunchbase.com/organization/elminda |
Identifiers & details
| Former names | elminda |
|---|---|
| Founded | 2006-1 |
| Employees (exact) | 26 |
| Offices | Oakville; Buffalo |
| Market cap | $11.8M |
| Status reason | Public on NASDAQ on Nov, 2021; |
Acquisitions & public offerings
| Acquired | Date | Amount |
|---|---|---|
| 2025-05 | $6.0M |
| Type | Date | Exchange | Ticker | Amount |
|---|---|---|---|---|
| 2021-11 | AIFF |